Evaluation of perceived threat differences posed by filovirus variants.

  title={Evaluation of perceived threat differences posed by filovirus variants.},
  author={Jens H Kuhn and Lori E. Dodd and Victoria Wahl-Jensen and Sheli R Radoshitzky and Sina Bavari and Peter B Jahrling},
  journal={Biosecurity and bioterrorism : biodefense strategy, practice, and science},
  volume={9 4},
In the United States, filoviruses (ebolaviruses and marburgviruses) are listed as National Institute of Allergy and Infectious Diseases (NIAID) Category A Priority Pathogens, Select Agents, and Centers for Disease Control and Prevention (CDC) Category A Bioterrorism Agents. In recent months, U.S. biodefense professionals and policy experts have initiated discussions on how to optimize filovirus research in regard to medical countermeasure (ie, diagnostics, antiviral, and vaccine) development… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 38 extracted citations

Similar Papers

Loading similar papers…